IPA's Subsidiary BioStrand Secures Second VLAIO Research GrantIPA subsidiary BioStrand receives grant to expand LENSai platform by linking...
IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics...
IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with...
IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from...
IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 In vivo, IND enabling evaluations of PolyTope®...
Traitement potentiel de la maladie de Parkinson et d'autres affections neurodégénératives IMMUNOPRECISE ANTIBODIES LTD. (la "Société" ou "IPA...
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's...
Potential to Treat Parkinson’s and Other Neurodegenerative Diseases IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX...
L'anticorps bloque l'interaction de liaison DFR/ACE2 par le biais d'un mécanisme d'action alternatif L'anticorps se lie à tous les variants...
Blocks the RBD/ACE2 binding interaction indirectly through an alternative mechanism of action Binds to all tested variants of concern, likely...
ImmunoPrecise et Genmab conviennent d'un partenariat technologique axé sur les maladies infectieuses ImmunoPrecise et Litevax font progresser le...
ImmunoPrecise and Genmab enter into a technology partnership targeting infectious disease ImmunoPrecise and Litevax advance SARS-CoV-2 vaccine...
Le criblage soutient les approches potentielles pour le traitement de variants émergents et futurs du SARS-CoV-2 grâce à une thérapie combinée...
The Screening Addresses Potential Approaches to Treating Emerging and Future Variants of SARS-CoV-2 Through Multi-Antibody Combination...
La direction fera le point sur les nouveaux variants du SRAS-CoV-2 qui suscitent de l'inquiétude (Royaume-Uni, Afrique du Sud et...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.